Nebulizer Delivery of Intranasal Scopolamine
Principal Investigator
Study Number
STUDY02001115
Summary
To develop a better way to administer anti-motion sickness medications using an intranasal nebulizer.
Phase
Pilot/Feasibility
Available at the following location(s)
- Lebanon
View more details at ClinicalTrials.gov
Do you need help with some of the labels on this page?
Read our glossary of terms